{{Rsnum
|rsid=2240466
|Gene=BAZ1B
|Chromosome=7
|position=73441939
|Orientation=minus
|GMAF=0.0877
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BAZ1B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 77.7 | 20.5 | 1.8
| HCB | 73.0 | 25.5 | 1.5
| JPT | 80.4 | 18.8 | 0.9
| YRI | 93.9 | 6.1 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 73.0 | 25.5 | 1.5
| CHD | 85.2 | 14.8 | 0.0
| GIH | 90.1 | 9.9 | 0.0
| LWK | 93.5 | 6.5 | 0.0
| MEX | 84.5 | 15.5 | 0.0
| MKK | 88.5 | 10.9 | 0.6
| TSI | 82.4 | 15.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19060911
|Trait=Triglycerides
|Title=Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
|RiskAllele=G
|Pval=1E-12
|OR=0.14
|ORtxt=[NR] SD increase
|OA=1
}}

{{PharmGKB
|RSID=rs2240466
|Name_s=
|Gene_s=BAZ1B
|Feature=
|Evidence=PubMed ID:19060911; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. (Initial Sample Size: 17,815 individuals; Replication Sample Size: NR); (Region: 7q11.23; Reported Gene(s): MLXIPL; Risk Allele: rs2240466-G); (p-value= 0.000000000001).This variant is associated with Triglycerides.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740227
}}

{{PMID Auto GWAS
|PMID=21490707
|Trait=None
|Title=Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.
|RiskAllele=A
|Pval=0.000001
|OR=0.1109
|ORtxt=[0.07-0.15] mg/day increase
|OA=1
}}

{{PMID|19185284|OA=1
}} Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study.

{{PMID|19435741|OA=1
}} Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people.

{{PMID|20502693|OA=1
}} Genetics and beyond--the transcriptome of human monocytes and disease susceptibility.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2240466
|overall_frequency_n=13
|overall_frequency_d=128
|overall_frequency=0.101562
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}